Lyell Immunopharma, Inc.
LYEL
$13.95
$0.211.53%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -19.65% | 2.75% | -22.65% | 15.48% | -8.10% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -28.93% | -3.19% | 59.95% | 58.13% | -32.21% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -20.11% | 2.44% | -20.49% | 16.30% | -8.72% |
|
|
|||||
| Total Current Assets | -20.11% | 2.44% | -20.49% | 16.30% | -8.72% |
| Net Property, Plant & Equipment | -6.45% | -5.77% | -5.28% | -5.71% | -11.36% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.91% | 5.39% | 56.68% | 0.39% | -16.14% |
| Total Assets | -11.26% | 3.11% | -16.65% | 5.84% | -10.32% |
|
|
|||||
| Total Accounts Payable | -29.06% | 89.01% | 12.66% | -24.00% | -9.36% |
| Total Accrued Expenses | 21.73% | 1.31% | 2.04% | 5.30% | -15.01% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.20% | 3.21% | 3.24% | 3.27% | 3.30% |
| Total Finance Division Other Current Liabilities | -44.44% | -94.55% | -- | -- | -13.52% |
| Total Other Current Liabilities | -44.44% | -94.55% | -- | -- | -13.52% |
| Total Current Liabilities | 7.90% | -25.23% | 55.00% | -13.62% | -10.61% |
|
|
|||||
| Total Current Liabilities | 7.90% | -25.23% | 55.00% | -13.62% | -10.61% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -6.47% | -5.81% | -5.34% | -4.96% | -4.61% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.90% | 1.93% | -80.72% | -11.52% | -3.53% |
| Total Liabilities | 0.49% | -16.21% | 16.50% | -8.88% | -7.23% |
|
|
|||||
| Common Stock & APIC | 0.26% | 2.67% | 3.31% | 3.96% | 0.30% |
| Retained Earnings | -2.72% | -1.49% | -9.52% | -2.70% | -3.05% |
| Treasury Stock & Other | -1,655.56% | -103.72% | 20.40% | 252.63% | -63.92% |
| Total Common Equity | -14.56% | 10.26% | -24.59% | 10.10% | -11.17% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -14.56% | 10.26% | -24.59% | 10.10% | -11.17% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -14.56% | 10.26% | -24.59% | 10.10% | -11.17% |
|
|
|||||